Absci Corporation (NasdaqGS: ABSI)
Health Care · Biotechnology · US
$8.94
-3.04% today · +113.9% 1Y
Absci Corporation (NasdaqGS: ABSI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.53B and employs 140 people.
Over the last twelve months the share price has gained 113.9%, trading between 2.24 and 12.06.
Tweenvest scores Absci Corporation across four factors: quality 45/100, value 56/100. Its strongest factor is value.
ABSI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.53B
- Revenue (TTM)
- $1.56M
- P/E
- —
- EPS
- -0.80
- Dividend yield
- —
- Beta (5Y)
- 2.28
- 52-week high
- $12.06
- 52-week low
- $2.24
- Avg volume (3M)
- —
- Shares outstanding
- 171.61M
- Employees
- 140
- Next earnings
- —
About Absci Corporation
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
- ISIN
- US00091E1091
- Founded
- 2011
- Listed since
- Jul 22, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX | $1.57B | $16.90 | -3.98% |
| uniQure N.V.NasdaqGS: QURE | $1.56B | $22.54 | -2.59% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.56B | CN¥21.63 | -4.46% |
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $1.55B | $23.95 | -1.40% |
| GenFleet Therapeutics (Shanghai) Inc.SEHK: 2595 | $1.51B | HK$31.94 | +6.82% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.50B | $29.09 | -1.09% |
| Ultragenyx Pharmaceutical Inc.NasdaqGS: RARE | $1.50B | $15.29 | +0.46% |
| Biotest GmbH & Co. KGaAHMSE: BIO0 | $1.48B | €33.20 | -0.60% |
Figures last refreshed Oct 4, 2026.